Poly Medicure shares declined 3.2% to close at ₹1,547.20 following the release of Q4 FY26 results. The stock movement reflects investor concerns over the company's profitability despite revenue growth, as reported by Business Standard. The latest trading data shows the stock has moved down from its previous close of ₹1,598.20, indicating continued pressure on the medical equipment manufacturer.
The company's consolidated net profit dropped 29.17% to ₹65.04 crore in Q4 FY26 compared to the same period last year. However, revenue from operations showed strong growth, increasing 21.25% to ₹534.51 crore in Q4 FY26 over Q4 FY25. Profit before tax (PBT) demonstrated robust performance with a 30.63% year-on-year increase to ₹85.22 crore in Q4 FY26. The company's market capitalization stands at ₹16,204.85 crore within the Hospitals & Allied Services sector, ranking 9th in its segment.
Operating EBITDA declined 8% to ₹112.1 crore in Q4 FY26 from ₹121.9 crore posted in Q4 FY25. The EBITDA margin contracted significantly to 21% in Q4 FY26 compared to 27.6% in Q4 FY25, representing a 667 basis points decline. This margin compression despite revenue growth indicates increased operational costs or pricing pressures. The company's cost structure shows less than 1% of operating revenues towards interest expenses and 18.06% towards employee costs for the year ending March 31, 2025.
Revenue from the infusion therapy segment grew 1.9% year-on-year to ₹256.1 crore in Q4 FY26. The renal segment showed stronger growth with revenue climbing 21.3% year-on-year to ₹56.2 crore. The others segment demonstrated exceptional performance with revenue increasing 55.2% year-on-year to ₹222.1 crore in Q4 FY26. Poly Medicure exports plastic medical disposables and surgical devices, manufacturing approximately 100 types of disposable medical devices across various therapeutic segments.
On a full year basis, the company's consolidated net profit fell 4.85% to ₹322.13 crore in FY26 despite revenue from operations increasing 12.3% to ₹1,875.25 crore over FY25. The board recommended a dividend of ₹3.5 per equity share of ₹5 each for financial year 2025-26. The company's PE ratio stands at 46.59 while the PB ratio is 5.86, reflecting its market position in the medical equipment sector. Poly Medicure operates as a Small Cap company incorporated in 1995, focusing on Medical Equipments & Accessories, Export Incentives, and Scrap segments.
